The Medication Management Program (MMP) at The Ohio State University College of Pharmacy is growing to serve more patients. With its larger staff, the program is projected to complete more than three hundred person-to-person comprehensive medication reviews weekly.
“We are excited about our growth and the opportunity to impact more patients,” said Ashley Sweaney, MMP pharmacy director. “Our full-time staff additions come with a variety of experience in managed care, community pharmacy and ambulatory care settings, and our student interns are getting an incredible opportunity to work directly with patients and apply what they are learning in the classroom.”
Since February, the MMP, a part of the Institute of Therapeutic Innovations and Outcomes (ITIO) at the College of Pharmacy, has expanded from a total staff of three to four full-time pharmacists, five full-time pharmacy technicians and 23 part-time pharmacy interns to meet the rising demand for medication therapy management services.
By Emily Caldwell
New research shows that the lungs become more inflammatory with age and that ibuprofen can lower that inflammation.
In fact, immune cells from old mouse lungs fought tuberculosis bacteria as effectively as cells from young mice after lung inflammation was reduced by ibuprofen. The ibuprofen had no effect on the immune response to TB in young mice.
This was a rare look at inflammation in the aging lung environment by Ohio State University scientists who study the immune response to TB. The researchers already knew that old mice had a harder time clearing TB from the lungs than young mice, but had not investigated the role of lung inflammation in that response.
“Very few researchers have linked inflammation to infectious disease in old age, even though TB in particular will drive that inflammation even further,” said Joanne Turner, associate professor of microbial infection and immunity at Ohio State and senior author of the study.
For those suffering excruciating pain from cluster headaches, relief may soon be available from an investigational device being studied in a national multicenter clinical trial. Recently, doctors at The Ohio State University Wexner Medical Center and the College of Dentistry performed the first surgery in the United States to insert a neurostimulator to provide relief from cluster headaches, which are more painful than migraines.
“Cluster headache is one of the most severe and disabling chronic pain conditions known to humankind. That’s why it’s important to look at options to help these patients,” said Dr. Ali Rezai, director of the Neuroscience program at Ohio State’s Wexner Medical Center and one of the scientific developers of this technology.